RWS Group Welcomes HRH The Duke of Gloucester
RWS was delighted to host His Royal Highness The Duke of Gloucester for the presentation of The Queen's Award for Enterprise: International Trade 2015.
RWS was delighted to host His Royal Highness The Duke of Gloucester for the presentation of The Queen's Award for Enterprise: International Trade 2015.
nsight from CP Kelco, a global leader in the specialty hydrocolloids market, provides a blueprint for the intelligent, cost-efficient deployment of gel permeation/size exclusion chromatography (GPC/SEC) in biopolymer manufacture.
The world's leading provider of translation, intellectual property and language support services is awarded the Queen's Award for Enterprise: International Trade 2015.
PRA Health Sciences (PRA) (NASDAQ: PRAH) is looking to hire new talent. To help attract potential employees from around the world, PRA, a leading global contract research organization (CRO), is launching a new Candidate Experience initiative. Just as PRA is finding innovative ways to improve the clinical development process, it is also developing creative strategies to meet the ever-growing need to identify highly skilled clinical research employees.
Munters and HB Group Combine Expertise and Products to Provide High Quality Air Treatment Solutions to Customers.
At the 29th Annual Symposium of The Protein Society (22-25th July, Barcelona, Spain) Natalia Markova, Principal Scientist- MicroCal, Malvern Instruments, will be presenting a workshop on how to enable high resolution protein interaction analysis using the latest MicroCal PEAQ-ITC system. Studies of biomolecular interactions are fundamentally important in all areas of the life sciences since such interactions drive and regulate all biological processes.
Closes previously announced clinical trials laboratory services joint venture transaction.
A series of highly interactive 2-day seminars delivered by Malvern Instruments, which encompassed expert presentations and 'up close' practical workshops showcasing the latest in nanoparticle characterization technology, have been widely praised by attendees.
Accutest Laboratories recently completed a first-to-file study for the fixed dose combination of Memantine 28 mg ER and Donepezil hydrochloride ten mg capsule in a record setting time of five days. This included volunteer screening, clinical, analytical, QA and report writing activities and submission.
The Haselmeier Group has decided to reinforce and reorganise its Executive Board. Mr. Gert Weber has been nominated by the Board of Directors of Medico Invest AG as Chief Executive Officer (CEO) of the Haselmeier Group. This nomination is effective starting July 1st, 2015. Mr. Weber brings more than 20 years of experience in the manufacturing and technological industries and has filled various executive management positions, the last being Managing Director and Vice President responsible for Operations and Information Technology (IT) at Avnet TS (former Magirus Group). With his experience and expertise, Mr. Weber shall contribute to strengthen Haselmeier's position and performance in the medical device industry and beyond.